Uh Oh, We've Lost That Page!
We're sorry...
You'll probably be able to find what you want by visiting the Home page. We'll try not to let that happen again.
New Stories
-
AdAlta reports two year cancer free survival after single dose of experimental mesothelioma therapy
August 5, 2026 - - Latest News -
Clarity Pharmaceuticals reports two more complete responses in prostate cancer trial
August 5, 2026 - - Latest News -
QIMR Berghofer and James Cook University deepen partnership to advance tropical health
August 5, 2026 - -
Neuren reports record DAYBUE sales as royalties rise and global expansion nears
August 5, 2026 - - Latest News -
AUScelerate programs channel major investment into heart and diabetes innovations
August 4, 2026 - - Latest News -
Entropy Neurodynamics advances TRP-8803 with 72 patient psychedelic therapy trial
August 4, 2026 - - Latest News -
Amplia announces agreement with Lilly to test narmafotinib combination in lung cancer
August 4, 2026 -